2016 Evergrande Snooker China Championship Final Time Higgins VS Bingham Live Video


[How to make braised pork belly fat and not greasy]_Production_Practice

鍦ㄥ仛绾㈢儳鑲夌殑鏃跺€欙紝瑕佹兂鎶婁簲鑺辫倝鍋氱殑鑲ヨ€屼笉鑵伙紝瑕佹帉鎻′竴瀹氱殑绐嶉棬锛岄鍏Patented patents and patents are available, and they are available in various ways, such as the following:It ‘s very hard to get around. It ‘s very rugged. It ‘s hard to come by, and it ‘s hard to come by.氫綑鐨勬补鑴傜┖鍑烘潵锛屽湪绾㈢儳鐨勬椂鍊欙紝涓€瀹氳鍔犲叆涓€鐐归閱嬶紝杩欐牱涔熸湁鍔╀簬鍚冭捣鏉ヨ偉鑰屼笉鑵汇€傚仛娉曚竴鍘熸枡锛氫簲鑺辫倝500g 鍐扮硸7-8鍧楋紙鍙牴鎹釜浜哄彛鍛宠皟鏁达級 妗傜毊銆侀鍙堕€傞噺 Hagi?鐢熸娊 鑰佹娊 缁嶅叴榛勯厭涓€灏忕 澶ф枡 钁卞钂滃仛娉曪細1銆佷簲鑺辫倝鍒囨垚鍧楀効鐘讹紝鍐锋按涓嬮攨锛屾按寮€鍚庣劘姘?鍒嗛挓鍚庢崬鍑恒€?銆侀攨涓笅娌癸紝甯︺€佸緟鍒?Do you want to make up? ╂ 椂 攷 史 叆 鏐 珐 埸 埾 妸 妸 馸 馸 雸 掲 寲 銆?The paper is very weak, and it ‘s awesome. It ‘s so beautiful. It ‘s beautiful. It ‘s so beautiful.鍜岃€佹娊锛屽甫浜旇姳鑲夊厖鍒嗕笂鑹插悗锛屽姞鍏ヨ懕濮滆挏銆佸ぇ鏂欍€侀鍙跺拰妗傜毊锛屽苟鍊掑叆娓╂按锛屾按閲忎互瓒呰繃浜旇姳鑲変负瀹滐紙涓€瀹氭槸娓╂按锛屽喎姘村奖鍝嶅彛鎰燂級銆?銆佸ぇ鐏倴寮€锛岀劧鍚庢崲灏忕伀鐐?0-40鍒嗛挓涓嶇瓑锛堟牴鎹釜浜鸿蒋纭姹傦級锛屽啀鍑洪攨鍓嶅崄鍒嗛挓鍔犲叆鐢熸娊涓€鍕哄拰鐩愰€傞噺锛堢洂鍚庡姞浠ラ槻姝㈣倝澶煷锛夛紝鏈€鍚庢敼澶х伀鏀舵眮鍎裤€佽鐩樸€傚仛娉曚簩涓绘枡锛氫簲鑺辫倝璋冩枡锛氬(浜旂墖) 鑽夋灉(涓€涓? 鍐 着 硸 (阃 傞 噺) 鍏  (鍏  鐩?涓€鑼跺寵)鑰佹娊(涓夊垎涔嬩竴姹ゅ寵) 鐢熸娊(閫傞噺) 鏂欓厭(涓€姹ゅ寵) 鍛崇簿(閫傞噺)鍋氭硶锛?銆?浜旇姳鑲夊垏楹诲皢澶у皬鐨勫潡锛屽啿娲楀共鍑€鍚庯紝鏀句竴姹ゅ寵鏂欓厭锛屾蹈娉′竴灏忔椂銆傛崬鍑烘潵娌ュ共銆?銆?閿呴噷鏀炬补鐓哥倰鑲夊潡鍒板井榛勩€?銆?Are you afraid of tea and tea? Jing Niu is so awkward: I am so sorrowful. What are you going to do?銆?鏀炬枡閰掍袱姹ゅ寵锛岀倰鍑犱笅锛屽啀鏀捐€佹娊锛岀敓鎶斤紝鐐掑寑銆?銆?鏀惧叆寮€姘达紝娣规病鑲夛紝杞叆鐮傞攨鐓ㄤ袱涓皬鏃惰皟鍏ョ洂銆?銆?鐓ㄥ埌閰ョ儌鐨勪簲鑺辫倝锛屾斁鍐扮硸澶х伀鏀舵眮锛屾檭鍔ㄩ攨锛屼笉瑕佺炕鍔ㄣ€?銆?鍒版堡姹佸潎鍖€鐨勮9鍦ㄨ倝涓婂氨濂戒簡锛佹斁鐐瑰懗绮炬彁鍛炽€傚仛娉曚笁涓绘枡锛氫簲鑺辫倝锛堣涓€灞傛补涓€灞傜槮鐨勶級璋冩枡锛氬(浜旂墖)鑰佹娊(涓夊垎涔嬩竴姹ゅ寵) 鐢熸娊(閫傞噺) 鏂欓厭(涓€姹ゅ寵) 鐧界硸锛堥€傞噺锛夎殱娌癸紙閫傞噺锛夊仛娉曪細1銆?浜旇姳鑲夊垏楹诲皢澶у皬鐨勫潡锛屽啿娲楀共鍑€鍚庯紝鏀鹃攨鍐呭姞姘达紝榛勬补濮滅墖锛屼腑鐏?銆傚緟娉℃搏浠樿锛屼笅姘存礂鍑€.A total of 2 銆?It’s awkward: I’m going to die.Do you want to upset you?Juma Chafei?銆佹斁鏂欓厭涓ゆ堡鍖欙紝鐐掑嚑涓嬶紝鍐嶆斁鑰佹娊锛岀敓鎶斤紝铓濇补锛夌倰鍖€4銆?鏀惧叆寮€姘达紝娣规病鑲夛紝杞叆鐮傞攨鐓ㄤ袱涓皬鏃惰皟鍏ョ洂銆?銆?鍒版堡姹佸潎鍖€鐨勮9鍦ㄨ倝涓婂氨濂戒簡锛佷笉闇€瑕佹斁鍛崇簿锛屽閲屽钩甯稿悆鏄洰濂界殑

[How to eat fish]_ making method _ method

[How to eat fish]_ making method _ method

In some areas of China, especially most of the southern regions and very few northern regions.

There are some ponds, oceans or lakes, and they will be rich in some fish and some animals, because fish are more nutritious, and the method is simple and popular.

Many people like to eat fish meat, so let’s find out how to make good fish!

First, braised catfish ① material catfish, ginger slices, light onion, dried pepper, a little Qixian bean paste, vinegar, spring onion, chicken essence ② practice 1.

Hot oil, add ginger slices, scallion white, dried chili, a little Qixian bean paste, after fragrant, 2.

Pour in the cut pieces of fish, add cooking wine and soy sauce, stir fry a few times, add a little vinegar over two or three minutes to remove the fishy smell.

(Because there is too much sauce added, so at this time, flip the fish pieces and let the sides touch the juice.

) 3.

Stir-fry for about 5 minutes, add water, and it’s almost half of the fish.

Anchovies age when they boil.

Then add some salt and a little soup.


Stew over medium heat for 10 minutes. If there is still a lot of juice after 10 minutes, you can turn on the high heat to collect the juice, add green onions, and the chicken is out of the pot.

2. Spicy sturgeon ① Material 1 sturgeon (weighing about 1500 grams, replacing the authentic beard of Zizhong Qiuxi River).

Seasoning Kimchi 50g, Pickled Pepper 50g, Pickled Ginger 50g, Single Garlic 30g, Dried Chili 20g, Chicken Powder 10g, MSG 5g, Starch 30g, Salt 8g, Dried Chilli Pepper, 15g20 grams of watercress, 5 grams of parsley, 8 grams of chives, 10 grams of wet starch, 500 grams of broth, 500 grams of mixed oil (the ratio of chicken oil and peanut oil is 1: 1).

② Method 1, slaughter the catfish, cut it into 2 cm wide pieces after washing the blood stains, put starch, salt code, and pickle for 15 minutes; chop the watercress in Minxian County; pickle the pickles and ginger, and cut them to 0 thickness.

2 cm thin slices; Wash the peppers and cut into small pieces; Wash the shallots and cut into green onions.

2. Put the mixed oil in the wok. When it is 50% hot, add the simmered bonito pieces for 1 minute, and then take out the oil control. Keep 50 grams of oil in the pot. When it is 70% hot, put the pickles and pickles.Duan, pickled ginger slices, chopped watercress, dried peppercorns, dried peppers, stir-fry with a single garlic on a small fire for 2 minutes until fragrant, add anchovy sticks, cook for 20 minutes on low heat, add chicken powder, season with MSGAfter serving, put in a plate, sprinkle green onions, and cilantro serve.

This dish features: hemp, spicy, tender, fresh, and fragrant.

Third, the catfish and sauerkraut tofu soup is fresh and delicious, with a little natural sour taste, and the fish and tofu are soft and tender.

Stew in a pot warmly, you can not only drink wine, but also accompany the meal, and it will also warm your stomach.

Trace seasoning: This vegetable meal is 231 kcal / person. ① 1 catfish (about 700g), pickled pickle 150g, northern tofu 250g, dried noodle 50g, 2 shallots, 3 ginger, 3 cloves of garlic, raw抽 1茶匙(5ml),料酒1汤匙(15ml),盐1茶匙(5g),油2汤匙(30ml)②做法鲇鱼去除内脏,以流动的水冲洗干净,沥去水分,切成1。
5cm thick fish fillet.

Sauerkraut is cut into 3 cm long pieces.

North tofu is cut into 3cm square pieces.

Wash the shallots and cut them into 3cm sections.

Garlic slices.

Dry noodles are softened with warm water.

Boil the water in the saucepan over high heat and add the chopped tofu pieces for 2 minutes to remove the fishy smell.

After that, put the sturgeon section in boiling water and blanch for 2 minutes to remove the earthy smell.

Heat the oil in the wok over high heat, add ginger slices and garlic slices, stir-fry the scent, and place in the scalloped bonito section. Cook the cooking wine, soak it, and continue frying for 2 minutes.

Take a casserole, add anchovies, sauerkraut, tofu cubes, and soft noodles. Pour in 2000ml of warm water, boil over low heat and simmer for 25 minutes.

Add salt to season and continue to simmer for 5 minutes.

[Can pea sprouts be eaten]_Pea sprouts_Can you eat_Can you eat

澶у閮界煡閬撳湡璞嗗彂鑺戒簡鏄笉鑳藉悆鐨勶紝鎵€浠ヨ嚜鐒惰€岀劧涔熷氨瑙夊緱璞岃眴鍙戣娊涔熶笉鑳藉悆銆傚叿浣撹睂璞嗗彂鑺戒簡鑳藉悆鍚楀苟涓嶆槸杩欐牱鍒ゆ柇鐨勶紝璞岃眴鍜屽湡璞嗕笉涓€鏍凤紝璞岃眴鍙戣娊鏄彨璞岃眴鑻楋紝鑰岃睂璞嗚嫍鏄彲浠ラ鐢ㄧ殑銆?1.鍙戣娊鐨勮睂璞嗕篃鏄兘鍚冪殑銆傝睂璞嗗彂鑺芥病鏈夋瘨鐨勶紝璞岃眴鑻楀張鍙€滈緳椤昏彍鈥濄€佲€滈緳椤昏眴鑻椻€濄€佲€滆澊铦惰彍鈥濈瓑绛夛紝灞炰簬鑻楄彍绫伙紝鍗冲皬妞嶄綋鑿溿€備富瑕佹槸椋熺敤璞岃眴鎵€鐢熸垚鐨勫辜瀚╄寧鍙跺拰瀚╂ⅱ銆傝睂璞嗚嫍鏃犺鏄崵鐐掋€佹竻鐐掋€佸仛姹ゃ€佹懂鐏攨锛岄兘涓嶅け涓轰笂涔樹匠鍝併€傝睂璞嗚嫍鍙e懗娓呴锛岃惀鍏讳赴瀵屻€?2.璞岃眴鍙戣娊鍜屽湡璞嗕笉涓€鏍凤紝璞岃眴鍙戣娊涔嬪悗杩樿兘鍚冿紝灏卞儚榛勮眴涓€鏍凤紝鍙互鐢ㄦ潵鍋氱敓璞嗚娊鍚冿紝璞岃眴鑺藉張鎴愰緳椤昏眴鑻楋紝鍙互椋熺敤锛屽苟涓旀棤璁烘槸鑽ょ倰銆佹竻鐐掋€佸仛姹ゃ€佹懂鐏What are you talking about?3.It ‘s a good idea. It ‘s fine. It ‘s fine. It ‘s a good idea. It ‘s very effective.仛娉曪細璞岃眴鑻楀幓鎺夌矖骞查儴鍒嗭紝鍙栧叾瀚╁彾锛屾礂鍑€锛屾播骞层€傚湪閿呬腑鍔犻€傞噺鐨勮壊鎷夋补锛屾斁涓嬪涓濓紝钂滄湯锛岃荆妞掓鐖嗛銆傛斁鍏ヨ睂璞嗚嫍缁х画鐓哥倰锛岀倰杞悗鏀句竴灏忓嫼瀛愭枡閰掞紝涓€鐐归鐩愶紝楦$簿锛岃皟鍛冲嵆鍙嚭閿呫€?.璞岃眴鑻楃厧楦¤泲鏉愭枡锛氳睂璞嗚嫍涓€鎶婏紝楦¤泲3-5涓紝椋熺洂灏戣銆傚仛娉曪細鈶犳妸楦¤泲涓€涓釜鎵撳紑鍒扮涓紝鐢ㄧ瀛愭悈鎷屽潎鍖€銆傗憽鎶婅睂璞嗚嫍娲楀噣锛屽垏纰庡悗鏀惧叆鎼呮媽鍧囧寑鐨勯浮铔嬩腑锛屽啀娆$敤绛峰瓙鎼呮媽鍧囧寑锛屾斁灏戣椋熺洂銆傗憿閿呮礂鍑€鏀惧叆椋熺敤娌癸紝鎶婁笂杩板鐞嗗ソ鐨勯浮铔嬭睂璞嗚嫍鍊掑叆閿呬腑灏忕伀鐓庤嚦2闈㈤噾榛勶紝鍗冲彲鍑洪攨銆?

[Difference between mandarin tea and small green mandarin]_Difference_Features

[Difference between mandarin tea and small green mandarin]_Difference_Features

Mandarin tea and Xiaoqing mandarin are two different tea products. There is a certain difference between them. Xiaoqing mandarin tastes very fresh and fresh, and has a sweet and refreshing feeling. It has been welcomed by many people in recent years.

There is a certain difference in the production of raw materials between mandarin tea and small green mandarin. In addition, there can be some judgments on the size and appearance.

There is also a certain difference in brewing. Xiaoqing orange is a bubble.

The difference between mandarin tea and small green mandarin 1. The difference in raw materials: small green mandarin is an immature mandarin, and most mandarin tea is made of big red mandarin, namely red mandarin.

Red mandarins will be sweet.

Green oranges are a little bit astringent, and red oranges are a bit sweet.

The green peel is called green peel. It is usually picked in October every year. The skin is thin, dark in color, mild in nature, hard and fragrant, spicy and bitter, and storage-resistant.The mandarin peel peeled from red mandarin is called two-red peel. Generally, it is picked in November each year. The skin is slightly thicker, he green is red, a small amount of soft and hard, mild in nature, spicy and bitter, and resistant to storage.

2. Composition difference: The content of “small green mandarin” aroma oil is higher than that of big mandarin, and the mandarin flavor is strong. From the point of view of medicine, green mandarin is also stronger than red mandarin. The older the medicine, the better.

Orange peel contains high content, polysaccharide content, hard, thin skin, bitter taste, aroma and resistance to the above characteristics; small green mandarin peel contains flavanone, which has bactericidal, anti-inflammatory, anti-HIV, Anti-mutagenic, antioxidant and other biological pharmacological activities.

3, the size difference: when it comes to big red mandarins and small green mandarins, we generally see this.

You said that the packaging was not opened and I didn’t see it clearly, so I will give you a close-up of the naked fruit: 4, appearance difference: you can see the appearance of the small green mandarin green brown, and the red mandarin orange red, the color will become timeAfter aging and gradual deepening, in fact, after looking at the appearance, everyone still pays attention to the material in the citrus fruit. After that, the raw materials of citrus tea are different from the citrus peel and the cooked tea.

5, brewing differences: and the above are all visible balance, so what will be different?

If you want to drink, you have to brew it. The brewing of the small green mandarin is very simple. You just need to throw it one by one and throw it directly into the brewing device.

The brewing of a small green tangerine and a red tangerine is a bit more complicated, because the portion is relatively large, so you have to take tea as needed, control the amount of tea according to personal taste and taste, and pay attention to the citrus peel and tea.Matching yo.

Shanghai Port Group (600018): faster-than-expected growth in performance Concerned about the new zone policy of the Free Trade Zone

Shanghai Port Group (600018): faster-than-expected growth in performance Concerned about the new zone policy of the Free Trade Zone

The 1H19 performance exceeded our expectations for the first half of 2019, which was announced by the company: revenue of $ 17.2 billion, a year-on-year decrease of 1.

8%; net profit attributable to mother 43.

73 ppm, corresponding to a profit of 0.

19 yuan, an annual increase of 29% (net profit increases by 9 each year.

8.7 billion), exceeding our budget expectations (an increase of 11%).

The decrease in revenue was mainly due to the decrease in increase in settlement income from real estate business2.

170,000 yuan, the real estate business (Long Beach project) in the first half contributed 52.4 million yuan in revenue, 1 year earlier.

3.6 billion.

As for the main port business, the container explosion in Shanghai’s home port has grown5.

0% (4 in the same period last year.

6%), as the company took the initiative to adjust the loading and unloading business of ore and coal, the bulk cargo explosion dropped by 18%.

5% reduction of total cargo tungsten carbide 1.


The total of the three expenses is reduced by 2.

110,000 yuan, mainly due to a significant reduction in financial expenses of 31% after early repayment of loans.

The company’s wholly-owned Shanghai Hong Kong Football Club realized a year of 武汉夜网论坛 losses (1H19 profit 0.

78 ppm, due to the introduction of foreign aid in the same period last year.

67 ppm), which is a preliminary (club net profit increase) 4 that our performance growth exceeded our expectations4.

4.5 billion accounted for 45% of the total net profit increase).

Development Trend The container explosion is growing moderately, and the uncertainty comes from external demand and trade negotiations. Pay attention to the free trade zone policy.

In the first half of this year, the company’s container bombs continued to grow moderately, mainly benefiting from the capacity of the automated terminals in Yangshan Port. Looking forward, the potential weakness of external demand may lead to growth, and the progress and results of trade negotiations will also bring uncertainty.

At the meeting of the Leading Group for Promoting the Integration Development of the Yangtze River Delta in June this year, it was clearly proposed to speed up the construction of the new area of the Shanghai Pilot Free Trade Zone. We recommend paying attention to the impact of relevant policies on the company.

Financial real estate and other businesses increased diversified income.

Finance: 1H19 came from Bank of Shanghai, and the investment income of Postal Savings Bank increased by 21% and 15%, accounting for 17% and 33% of net profit.

Real estate: The company still has the Long Beach project (estimated investment of 18.5 billion US dollars) and the military industry road project (estimated total investment of 82).

700 million US dollars, the military industry road project is under construction and has not yet begun sales. It is expected that it will continue to contribute profits to the company in the future.

Earnings forecasts and estimates Taking into account the high base in 4Q19 (mainly from the one-time gain from the sale of Star Bund Company), we expect earnings to be replaced.

According to the company’s annual shareholders’ meeting, the company’s budget for 2019 net profit is 9 billion US dollars, a year-on-year decrease of 12.


We maintain our 2019 net profit forecast of RMB96.

10 ppm and 2020 net profit, forecasting RMB 98.

7.7 billion.

The current priority is 17.

6 times 2019 P / E ratio and 17.

1x 2020 P / E ratio.

Maintain Outperform rating and 9.

Target price of 12 yuan, corresponding to 17.

6 times 2019 P / E ratio and 17.1x 2020 price-earnings ratio, compared with the recent merger of 25.

3% upside.

The risk surge grew faster than expected, and the settlement progress of the real estate business exceeded expectations.

[Homemade Practices and Precautions for Braised Turtles]_How to_How to do

銆 愮 儿 雑 х 敳 楸 餸 Ning drafts 弛 娉 樰 儉 ㄦ 剰 浜 嬮 “銆 慱 許 庝 箞 锅 歘 傘 傡 傘 傡 傘 傡 傍 傍 炍 傍 傍?
鐢查奔鍛抽亾鍗佸垎鐨勯矞缇庯紝鍚湁澶氱缁寸敓绱犲凡缁忓井閲忓厓绱狅紝涓€鐩撮兘鏄粙琛ョ殑鐝嶅搧锛岀敳楸煎彲浠ュ鍏嶇柅鍔涖€佹彁楂樿韩浣撶殑鎶楃梾鑳藉姏浠ュ強璋冭妭鍐呭垎娉岀殑鍔熻兘锛屽湪鎴戝浗鍏充簬鐢查奔鐨勫姛鏁堝緢鏃╀箣鍓嶅氨鏈夋枃瀛楄杞斤紝鍚屾椂鐢查奔杩樺睘浜庘€滅編椋熶簲鍛宠倝鈥濅箣涓€”Are you sure?” “Ammonia” is a brand-new version of a child’s heart and a child’s heart. It’s more like a manuscript than a manuscript. What is it? 銆?What?Zha Ben Ben Shao?1.鐢查奔浠庝腑闂存姏寮€锛屽墧闄ら粍鑹茬殑鑴傝偑銆傜敳楸兼斁鍏ョ泦涓紝鐑т竴澹跺紑姘达紝娣嬪叆鐩嗕腑銆傚埉闄ょ敳楸艰韩涓婄殑绮楃硻鐨勮啘銆傜劧鍚庡皢鐢查奔鏂╀欢骞剁劘姘淬€傚噯澶囧鐗囥€佽懕娈电瓑銆傞攨鐑补锛屾斁鍏ヨ懕銆佸鐐掗銆?.鏀惧叆鐢查奔鍧椼€傛斁鍏ユ枡閰掔炕鐐掋€傚姞鍏ョ敓鎶姐€佽€佹娊缈荤倰涓婅壊銆傚姞姘村ぇ鐏儳寮€锛屾斁鍏ラ緹鐢层€傛斁鍏ョ硸锛屽皬鐏倴鐓崐灏忔椂銆傚姞鍏ョ洂璋冨懗杞ぇ鐏敹姹佸嵆鍙€?娉 ㄦ 剰 浜 嬮 」adze?1.Cha Cha Ben Tao (嬡 笂 璄 堯 瑍 鑹 鑹 茶 Just set up)The awards are given by the awarding of the awards to protect the arc, and the arc is squeezed out. The current version of the check is made, and the test is made, and the test is carried out, and the shoulders are closed.I ‘m sorry, I ‘m sorry, I ‘m not sure what to do, I ‘m looking at it, I ‘m going to do it, I ‘m going to do it, I ‘m going to do it.What are you going to do? Click on the right button and click on the right button. Click on the button to get started. Do you want to know how to perform a good job?銆佺敳楸艰韩涓婄殑涓€灞傝啘蹇呴』鍘婚櫎锛岀敤寮€姘寸儷涓€涓嬪氨寰堝鏄撴挄鎺変簡銆?3.Sorry, don’t you know?.姝荤敳銆佸彉璐ㄧ殑鐢查奔涓嶈兘鍚冿紱鐓庣叜杩囩殑槌栫敳娌℃湁鑽敤浠峰€?

Placco (603566) Annual Report Comments: 19% growth in performance is basically in line with expectations

Placco (603566) Annual Report Comments: 19% growth in performance is basically in line with expectations

Core point of view: 2018 performance growth increased by 19%, basically in line with expectations.

The company released its 2018 annual report, which reported revenue6.

1 ‰, an increase of 15% over ten years, net profit attributed to the mother1.

400 million US dollars, an annual increase of 19%, net profit after deduction of 87.28 million yuan, an annual increase of 29%, performance growth comes from the new listing of swine vaccines and poultry vaccine sales benefit the high prosperity of the bird chain.

New pig seedling products are gradually contributing to the increase of poultry seedlings benefiting downstream booming companies to achieve restorative growth. Sales of pig seedlings1.

USD 900 million, an increase of 18% per year. The increase in market-based vaccines for pigs mainly comes from the company’s increased swine ring subunit genetically engineered vaccines, and the promotion of new products of ring water adjuvant inactivated vaccines has gradually contributed to the increase in revenue.

The poultry seedlings benefited from the high prosperity of the poultry industry chain, and the company’s poultry vaccines have achieved restorative growth and reported sales revenue.

1.4 billion, an increase of 17% in ten years.

The joint establishment of Sino-Pulmonary Biological has obtained a rich reserve of vaccines for foot-and-mouth disease vaccine qualification reserve. It has been reported that Sino-Pulmonary Biological obtains a new veterinary drug certificate for swine O-A inactivated vaccine. The product launch will open up the company’s profit space.

In addition, the company’s swine pseudorabies inactivated vaccine has obtained new veterinary drug certificates, other reserve varieties of pig round-branch double vaccine, pseudo-rabies genetic engineering vaccine, new (Ⅶ) flow double vaccine and other key products are currently under research and orderly development, product echelonStrive to continue to enrich 苏州桑拿网 and enhance the company’s competitiveness.

The 19-21 results were 0.

51 yuan / share, 0.

67 yuan / share, 0.

The listing of multiple new varieties of 81 yuan / share company will promote the company’s performance growth.

EPS is expected to be 0 in 2019-2021.

51 yuan, 0.

67 yuan, 0.

81 yuan, based on the latest closing price, the company’s PE estimate for 2019 is 29 times, and the current industry average PE (TTM) is 29 times.

It is expected that the China-Puerto Biology vaccine for foot-and-mouth disease will be launched in 2020. Foot-and-mouth disease vaccine is the largest variety in the industry market. In the future, sales revenue will increase the company’s income and increase. Considering that the sales elasticity brought by foot-and-mouth disease sales income is the same as other varieties.Industry-comparable 朴妮唛脱胸罩新闻 companies bring performance performance flexibility. Companies should be given a valuation premium, and given companies a 33x estimate in 2019, the reasonable value is 16.

83 yuan / share, maintain “Buy” rating.

Risk reminder: New products are not listed as expected; product sales are not as expected; disease risk, etc.

Antu Bio (603658) 2019 Third Quarterly Report Review: Chemiluminescence Imports Replace Responsible Tasks and Long Road Performance Maintains High Growth Rate

Antu Bio (603658) 2019 Third Quarterly Report Review: Chemiluminescence Imports Replace Responsible Tasks and Long Road Performance Maintains High Growth Rate

I. Event Overview On October 28, 2019, the company released the third quarter of 2019 report: operating income for the first three quarters, net profit attributable to mothers, net profit attributable to mothers after deductions were 18 respectively.

9.4 billion, 5.

3.8 billion, 5.

20 ppm, a 39-year increase of 39.

22%, 30.

87%, 31.


Among them, the operating income in the third quarter was attributed to the net profit of the mother, and the net profit attributed to the mother after deduction was 7, respectively.

14 billion, 2.

18 billion, 2.

120,000 yuan, an increase of 39 in ten years.

53%, 32.

42%, 32.


Cash flow from operating activities 5.

34 ppm, an increase of 23 per year.


Second, analysis and judgment 2019Q3 continued the trend of the second quarter, showing a high growth rate, focusing on the progress of product approval under the focus of high R & D 1) Affected by the high base of 2018Q1, the significant growth rate of 2019Q1-Q3 performance improved quarter by quarter.

① The revenue side is accelerating due to the high growth of reagents and co-construction business.

In the first three quarters of 2019, revenues increased by 39 in ten years.

22%, of which the third quarter revenue increased by 39 in ten years.

53%, basically the same as the growth rate in the first three quarters, and the revenue growth rate in several years has shown a significant acceleration in 2018 (excluding the high base of Q1 growth in 2018). We estimate that the chemiluminescence reagents remain relatively fast.The growth rate and the incremental income contribution of the co-construction business; ② Profit-side analysis, multiple growth levels match the revenue growth rate.

In the single quarter, the growth rate of net profit after deducting non-returning mothers showed that the growth rate of 18Q4-19Q3 showed a quarterly speed increase (the multiple growth rates were 23 respectively.

64%, 30.

14%, 30.

92%, 32.

36%), mainly due to the high base in 2018Q1 (2018Q1 revenue, net profit or growth rate were 71.

87%, 42.

(43%, much higher than the growth rate in the first three quarters). Overall, we believe that the trend of net profit growth and revenue growth are matching and are also affected by the high growth of reagents and co-construction.

2) The increase in the proportion of co-construction business income and the increase in the rate of research and development expenses have led to a slight shift in net interest rate.

Analysis of gross profit margin, affected by agency and co-construction business, the gross profit margin fell in the first three quarters.

14pct to 66.


The company’s continuous technological innovation comes from high R & D expenditures: the company generated R & D expenses in the first three quarters.

26 ppm, a 56-year increase of 56.

83%, much higher than revenue growth; R & D expenditures11.

92%, an increase of 1 over the same period last year.

34pct is mainly the investment in the research and development of new kit products.Selling expenses in the first three quarters15.

84%, an increase of 0 a year.

07 points; management expense ratio 4.

54%, a decrease of 0 per year.

27 points.

The net interest rate is 28.

95%, a decrease of 1 per year.

75pct; we expect the subsequent gross profit margin to remain stable, the overall revenue scale to expand and dilute costs and expenses (period expense ratio decreased), so that the net interest rate is gradually reduced, especially R & D investment (higher proportion), we will continue to track itsProduct approval and volume rhythm.

3) Affected by agency and co-construction business, the operating cash flow growth rate is lower than the profit growth rate.

With the increase of agency and co-construction business income, the receivables turnover rate decreased by 0.

90pct to 4.

21%, we expect the account receivables turnover rate will still slowly decline; due to the company’s enhanced upstream bargaining power, the accounts payables turnover rate continues to decrease1.

54 points to 5.


As a result, the operating cash flow in the first three quarters of 2019 increased by 23% per year, which was slightly lower than the growth rate of profits, and the overall quality still showed higher growth.

The import of chemiluminescence has a long way to go. Product and technological innovation are the foundation of life. 1) Innovative research and development continue. Luminous products are still the main force for development.

In terms of testing reagents, six new product registration certificates were obtained in the third quarter (five of which were kit products), and a total of 26 new product registration certificates were terminated on September 30, further enriching the company’s product line and continuously satisfying the marketdemand.

Initially, 1,000 new units are expected to be completed, and we expect the final inventory to exceed 4,000 units, which will drive the volume of supporting reagents.

2) Strategic layout of laboratory automation lines, a step further in high-end manufacturing.

The laboratory automation assembly line is one of the company’s strategic product layouts. At present, the product marketing value positioning, pricing, team building and sales process establishment have been initially completed.

The new product “Autolas B-1 series of automatic biochemical immune line” was released, which 杭州桑拿网 adopted the same configuration of the traditional line to save 60% -80% of space.

3) In the direction of microbial detection, nucleic acid POCT, biochemistry, etc.

The company’s microbiological testing products have a variety of varieties and grow rapidly. Among them, the microbial flat plate series products are larger in the predetermined market, and the listing of automated blood culture systems and supporting culture bottles has replaced the company’s market size in the domestic bacterial culture field.

In the direction of nucleic acid POCT, the company signed a share subscription agreement and a joint venture agreement with Mobidiag of Finland. In May this year, Zhengzhou Antu Mobi Molecular Diagnostic Technology Co., Ltd. was established. It is responsible for respiratory, fixation and meningitis based on 重庆耍耍网 Novodig nucleic acid POCT technology platformDevelopment, production and sales of target nucleic acid fully automatic POCT products.

In the direction of biochemical products, Antu Bio, Beijing Antu Bio, and Canon’s three-party concepts are gradually consistent, and the fusion effect is significant.

Third, investment recommendations We believe that chemiluminescence is a high-quality track in the early stage of import substitution. The company’s luminous products rank among the top in China, with rich growth momentum, and are expected to continue to achieve high growth.

We expect EPS to be 1 in 2019-2021.

77, 2.

48, 3.

41 yuan, according to the closing price on October 28, 2019 corresponding to PE is 57, 40, 29 times.

For the first time, refer to the assessment of comparable companies and industry division, and give a “cautious recommendation” rating.

4. Risk warning: product quality risk; market competition risk; policy change risk.

Changchun High-tech (000661): Investing in overseas dual-antibody platforms, lidocaine transdermal patch innovation pipeline layout is becoming increasingly rich

Changchun High-tech (000661): Investing in overseas dual-antibody platforms, lidocaine transdermal patch innovation pipeline layout is becoming increasingly rich
Events: (1) The company announced that it has signed an agreement with Antai Pharmaceuticals to invest no more than 62 million yuan to purchase the “5% Lidocaine Transdermal Patch” sales rights and global production rights in mainland China. (2) The company announced that it plans to establish an antibody platform joint venture with Amesino in the United States.Among them, Amesino holds 80% equity, Changchun Gaoxin invested 30 million yuan, and holds 20% equity. Comments: (1) 5% lidocaine patch (LMP) is a polyester patch containing lidocaine 700 mg, 10 cm x 14 cm in size, which blocks damaged C fibers through local diffusion of lidocaineThe barrier effect of sodium channel of Aδ fiber and patch achieves analgesic effect.LMP is recommended by the European Medicines Agency and the US FDA as a first-line treatment for postherpetic neuralgia, especially for patients who cannot tolerate systemic drugs, such as renal insufficiency.LMP is also recommended for other local neuropathic pain.In 2018, the national local anesthesia market was nearly 1 billion US dollars, especially drugs such as rocaine, lidocaine and tetracaine.Lidocaine 2018 PDB Sample Hospital Sample 1.1 ppm, an increase of 67% before 2017, most of which are injections and capsules. Only Beijing Tide Pharmaceutical Factory was approved for lidocaine gel patch. Such products were listed in the year when it was launched in 2018.40,000 yuan, 19H1 budget of 20,000 yuan, good growth momentum.There is currently no 5% lidocaine transdermal patch on the market in China. Anengtai Pharmaceutical has developed NAL1282 Lidocaine 5% patch.The company and Anengtai Pharmaceutical plan to jointly build a hydrogel patch pharmaceutical strategic production base and a hydrogel patch pharmaceutical laboratory in Changchun. Changchun High-tech is responsible for purchasing related instruments and equipment. Anengtai Pharmaceutical is responsible for upgrading the production baseGMP certification and production licenses that meet the requirements of the US FDA, EU EMA, China NMPA and global requirements.After the product is launched, Changchun High-tech is responsible for regional sales in China, and Anengtai Pharmaceutical is responsible for overseas regional sales.In the long run, the company will use the platform technology of transdermal patch preparations as an entry point to imitate and combine innovations to develop improved new drugs for transdermal preparations. (2) Bispecific antibody drugs are one of the most popular directions in the field of tumor immunotherapy in the world. At present, only three diabody antibody drugs are on the market, and domestic dual antibody projects are in the IND 南京桑拿网 or early clinical stage.The proposed antibody platform joint venture company will first select known targets for secondary development and speed up product development. Subsequently, it will develop recombination and innovative new target bifunctional antibody drugs. Earnings Forecast and Estimate: Maintain forecast for EPS 7 of 19-21.95/10.48/13.73 yuan. After the restructuring, the EPS after diluted for 19 years is 8.99 yuan (corresponding to 38X / 28X in 19-20 years).The company’s stock exchange has been steadily advancing. The current performance is highly compatible with the estimates, and the rating of “Buy” is maintained. Risk warning: uncertainty in the progress of the stock exchange; the progress of new product development is not up to expectations.